You’ve probably been there — staring at another diet plan, another gym ad, another promise of results. And if you’ve ever ...

The research involves a thumbnail-sized patch with micro-needles, reportedly so fine they cause no pain or pierce blood vessels, allowing painless drug delivery through skin ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

Danish drugmaker Novo Nordisk has announced that it is expanding patient access to Wegovy (semaglutide) injection 2.4 mg in ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Eli Lilly's stock suffered a nearly 12% loss in markets Thursday despite strong earnings, in what analysts say is an ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The ...

Wegovy is an injectable medication that contains ... Many people have a fear of needles and prefer oral medications over injectables. Due to its increased popularity and occasional supply chain ...

Rules are now being tightened to try to minimise the risk of this happening. Because Wegovy, Mounjaro and Ozempic pens all contain needles, they are considered clinical waste and should be disposed of ...